Atlas Trials

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

Clinical trial NCT00486187 · COMPLETED

Trial details

NCT number
NCT00486187
Sponsor
Dr. Milan Gupta
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2006-04-01
Primary completion
2009-06-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.